3 ms·

Nice to see! This was developed in the UK for £11million and sold to Bristol Myers Squib for USD 14billion... https://wellcome.org/news/new-treatment-for-schi

• hackernewds 2y ago
  That's quite a handsome return. Which BMS feels empowered to do to since they can charge exorbitant amounts for it I often am against the narrative that every pill should be priced at the cost of manufacturing + healthy margin, since by that logic the first pill should cost billions to cover for the R&D. In this case, it doesn't quite translate.